Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.
Identifieur interne : 001D03 ( PubMed/Corpus ); précédent : 001D02; suivant : 001D04Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.
Auteurs : Daniella M F. Paiva ; Vivian O. Rodrigues ; Marcelle G. Cesca ; Pamella V. Palma ; Isabel C G. LeiteSource :
- BMC women's health [ 1472-6874 ] ; 2013.
English descriptors
- KwdEn :
- Adult, Aged, Brazil (epidemiology), Breast Neoplasms (epidemiology), Breast Neoplasms (pathology), Breast Neoplasms (therapy), Cross-Sectional Studies, Female, Humans, Lymph Node Excision, Lymphedema (epidemiology), Lymphedema (pathology), Lymphedema (therapy), Middle Aged, Prevalence, Quality of Life, Severity of Illness Index, Women's Health.
- MESH :
- geographic , epidemiology : Brazil.
- epidemiology : Breast Neoplasms, Lymphedema.
- pathology : Breast Neoplasms, Lymphedema.
- therapy : Breast Neoplasms, Lymphedema.
- Adult, Aged, Cross-Sectional Studies, Female, Humans, Lymph Node Excision, Middle Aged, Prevalence, Quality of Life, Severity of Illness Index, Women's Health.
Abstract
Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.
DOI: 10.1186/1472-6874-13-6
PubMed: 23406386
Links to Exploration step
pubmed:23406386Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.</title><author><name sortKey="Paiva, Daniella M F" sort="Paiva, Daniella M F" uniqKey="Paiva D" first="Daniella M F" last="Paiva">Daniella M F. Paiva</name><affiliation><nlm:affiliation>School of Medical Sciences and Health, Juiz de Fora, Brazil. jcndani@yahoo.com.br</nlm:affiliation></affiliation></author><author><name sortKey="Rodrigues, Vivian O" sort="Rodrigues, Vivian O" uniqKey="Rodrigues V" first="Vivian O" last="Rodrigues">Vivian O. Rodrigues</name></author><author><name sortKey="Cesca, Marcelle G" sort="Cesca, Marcelle G" uniqKey="Cesca M" first="Marcelle G" last="Cesca">Marcelle G. Cesca</name></author><author><name sortKey="Palma, Pamella V" sort="Palma, Pamella V" uniqKey="Palma P" first="Pamella V" last="Palma">Pamella V. Palma</name></author><author><name sortKey="Leite, Isabel C G" sort="Leite, Isabel C G" uniqKey="Leite I" first="Isabel C G" last="Leite">Isabel C G. Leite</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23406386</idno><idno type="pmid">23406386</idno><idno type="doi">10.1186/1472-6874-13-6</idno><idno type="wicri:Area/PubMed/Corpus">001D03</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D03</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.</title><author><name sortKey="Paiva, Daniella M F" sort="Paiva, Daniella M F" uniqKey="Paiva D" first="Daniella M F" last="Paiva">Daniella M F. Paiva</name><affiliation><nlm:affiliation>School of Medical Sciences and Health, Juiz de Fora, Brazil. jcndani@yahoo.com.br</nlm:affiliation></affiliation></author><author><name sortKey="Rodrigues, Vivian O" sort="Rodrigues, Vivian O" uniqKey="Rodrigues V" first="Vivian O" last="Rodrigues">Vivian O. Rodrigues</name></author><author><name sortKey="Cesca, Marcelle G" sort="Cesca, Marcelle G" uniqKey="Cesca M" first="Marcelle G" last="Cesca">Marcelle G. Cesca</name></author><author><name sortKey="Palma, Pamella V" sort="Palma, Pamella V" uniqKey="Palma P" first="Pamella V" last="Palma">Pamella V. Palma</name></author><author><name sortKey="Leite, Isabel C G" sort="Leite, Isabel C G" uniqKey="Leite I" first="Isabel C G" last="Leite">Isabel C G. Leite</name></author></analytic><series><title level="j">BMC women's health</title><idno type="eISSN">1472-6874</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Brazil (epidemiology)</term><term>Breast Neoplasms (epidemiology)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (therapy)</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (pathology)</term><term>Lymphedema (therapy)</term><term>Middle Aged</term><term>Prevalence</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Women's Health</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Brazil</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Middle Aged</term><term>Prevalence</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Women's Health</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23406386</PMID><DateCreated><Year>2013</Year><Month>02</Month><Day>20</Day></DateCreated><DateCompleted><Year>2013</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6874</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2013</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>BMC women's health</Title><ISOAbbreviation>BMC Womens Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.</ArticleTitle><Pagination><MedlinePgn>6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1472-6874-13-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded. Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in 5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the morbidity of this disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>Daniella M F</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>School of Medical Sciences and Health, Juiz de Fora, Brazil. jcndani@yahoo.com.br</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Vivian O</ForeName><Initials>VO</Initials></Author><Author ValidYN="Y"><LastName>Cesca</LastName><ForeName>Marcelle G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Palma</LastName><ForeName>Pamella V</ForeName><Initials>PV</Initials></Author><Author ValidYN="Y"><LastName>Leite</LastName><ForeName>Isabel C G</ForeName><Initials>IC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Womens Health</MedlineTA><NlmUniqueID>101088690</NlmUniqueID><ISSNLinking>1472-6874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2000;39(3):349-54</RefSource><PMID Version="1">10987232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Oncol. 2011 Oct;34(5):506-10</RefSource><PMID Version="1">21127413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2001 May;181(5):434-9</RefSource><PMID Version="1">11448437</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 2002 Nov;137(11):1253-7</RefSource><PMID Version="1">12413312</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2003 Feb;185(2):127-30</RefSource><PMID Version="1">12559441</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(1):47-57</RefSource><PMID Version="1">12779081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Cancer. 2004 Jan-Mar;41(1):8-12</RefSource><PMID Version="1">15105573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2004 Sep-Oct;10(5):405-11</RefSource><PMID Version="1">15327493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2007 Mar 10;334(7592):517</RefSource><PMID Version="1">17307761</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2007;7:166</RefSource><PMID Version="1">17760981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2008 Jan;35(1):65-71</RefSource><PMID Version="1">18192154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Jul;110(2):337-42</RefSource><PMID Version="1">17851756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Jul 20;26(21):3536-42</RefSource><PMID Version="1">18640935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jan;113(2):383-91</RefSource><PMID Version="1">18297429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jan 20;27(3):390-7</RefSource><PMID Version="1">19064976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Nurs. 2009 Feb 12-25;18(3):166-72</RefSource><PMID Version="1">19223801</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Apr;16(4):979-88</RefSource><PMID Version="1">19194754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2009;7(1):29-45</RefSource><PMID Version="1">19302022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Apr 20;27(12):2007-14</RefSource><PMID Version="1">19289624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hong Kong Med J. 2009 Jun;15(3 Suppl 4):8-12</RefSource><PMID Version="1">19509430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Jul;16(7):1959-72</RefSource><PMID Version="1">19365624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Aug;116(3):539-41</RefSource><PMID Version="1">19184413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Oct;117(3):559-60</RefSource><PMID Version="1">19205875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cad Saude Publica. 2009 Nov;25(11):2455-66</RefSource><PMID Version="1">19936483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2010 Mar-Apr;16(2):147-55</RefSource><PMID Version="1">19968661</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Nov 15;116(22):5138-49</RefSource><PMID Version="1">20665892</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46</RefSource><PMID Version="1">20978176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 2010 Nov;145(11):1055-63</RefSource><PMID Version="1">21079093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2010 Dec;19(6):506-15</RefSource><PMID Version="1">20561790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2010 Sep;43(3):118-27</RefSource><PMID Version="1">21226414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2000;39(3):355-72</RefSource><PMID Version="1">10987233</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016387" MajorTopicYN="N">Women's Health</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3577444</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>06</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23406386</ArticleId><ArticleId IdType="pii">1472-6874-13-6</ArticleId><ArticleId IdType="doi">10.1186/1472-6874-13-6</ArticleId><ArticleId IdType="pmc">PMC3577444</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D03 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001D03 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23406386
|texte= Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23406386" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |